SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,937 | -24.5% | 17,273 | +1.2% | 0.00% | – |
| Q2 2023 | $79,389 | +39.8% | 17,073 | +38.9% | 0.00% | – |
| Q1 2023 | $56,794 | -42.8% | 12,293 | 0.0% | 0.00% | – |
| Q4 2022 | $99,327 | +50.5% | 12,293 | +3.0% | 0.00% | – |
| Q3 2022 | $66,000 | +6.5% | 11,933 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | -36.7% | 11,933 | +0.1% | 0.00% | – |
| Q1 2022 | $98,000 | -44.6% | 11,923 | 0.0% | 0.00% | – |
| Q4 2021 | $177,000 | -16.1% | 11,923 | +6.9% | 0.00% | – |
| Q3 2021 | $211,000 | +1.9% | 11,156 | 0.0% | 0.00% | – |
| Q2 2021 | $207,000 | +3.5% | 11,156 | +26.9% | 0.00% | – |
| Q1 2021 | $200,000 | – | 8,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |